Skip to main content
. 2015 May 18;8:1091–1102. doi: 10.2147/OTT.S31916

Table 5.

PICO for the role of ruxolitinib in MPN-MF-associated symptoms

Patients Any patients doctors consider in need of treatment for symptoms
Intervention Ruxolitinib
Comparator No standard therapy for this category of patients
Outcome Response on symptoms

Abbreviations: PICO, participant, intervention, comparator, and outcome; MPN-MF, myeloproliferative neoplasm-associated myelofibrosis.